Skip to main content

Table 3 Predictors of hospital readmission within 1 year of TAVR discharge

From: Association between transitional care factors and hospital readmission after transcatheter aortic valve replacement: a retrospective observational cohort study

 

HR

95% CI

p value

Demographics

 Age

1.01

(1.0–1.02)

0.20

 Female sex

0.72

(0.53–0.98)

0.03

 Dependent living

1.03

(0.85–1.24)

0.77

Clinical Characteristics

 NYHA class

  I/II

reference

  

  III

1.00

(0.82–1.21)

0.96

  IV

1.43

(1.07–1.91)

0.02

 Frailty

1.07

(0.76–1.50)

0.69

Cardiac comorbidities and interventions

 Atrial fibrillation

1.34

(1.08–1.66)

0.01

 Prior heart failure

1.08

(0.81–1.43)

0.60

 Prior myocardial infarction

0.98

(0.78–1.22)

0.84

 PCI

1.18

(0.92–1.52)

0.20

 CABG

0.90

(0.70–1.15)

0.41

Medical comorbidities

 Diabetes

1.05

(0.86–1.29)

0.65

 Cerebrovascular disease

0.82

(0.56–1.18)

0.28

 Peripheral vascular disease

1.18

(1.02–1.37)

0.02

 Dementia

1.22

(0.69–2.15)

0.50

 Dialysis

1.67

(1.06–2.65)

0.03

 Lung disease

1.23

(0.91–1.66)

0.18

 Liver disease

2.00

(0.63–6.37)

0.24

 Peptic ulcer disease

1.52

(1.09–2.12)

0.01

 History of bleeding

1.10

(0.81–1.51)

0.54

Laboratory markers

 eGFR

1.00

(0.99–1.0)

0.36

 Hemoglobin

0.99

(0.99–1.0)

< 0.001

Echocardiographic findings

 Left ventricular dysfunction

0.73

(0.54–0.98)

0.04

Procedural characteristics

 Urgent procedure

0.98

(0.58–1.65)

0.94

 Valve in valve

0.65

(0.48–0.87)

0.004

 Self-expandable prosthesis

0.98

(0.84–1.14)

0.76

 Non-femoral vascular access site

1.40

(1.08–1.81)

0.01

 TAVR year

0.97

(0.92–1.03)

0.31

Procedural complications

 Stroke

1.09

(0.82–1.45)

0.56

 Permanent pacemaker

1.21

(0.83–1.77)

0.31

 Delirium

1.24

(0.83–1.85)

0.29

 Bleeding, vascular complication or transfusion

1.33

(1.18–1.50)

< 0.001

Echocardiographic findings post-TAVR

 Mitral regurgitation

  Nil/trace

reference

  

  Mild

1.23

(1.10–1.38)

< 0.001

  Moderate/Severe

1.26

(1.03–1.54)

0.03

 Aortic regurgitation

  Nil/trace

reference

  

  Mild

1.21

(0.97–1.52)

0.10

  Moderate/Severe

1.13

(0.75–1.70)

0.57

Previous health resource utilization

 Hospitalization 30 days before TAVR

1.05

(0.92–1.20)

0.48

Transitional care factors

 Rehabilitation

1.34

(1.11–1.62)

0.002

 Home care

1.18

(0.96–1.44)

0.12

 Family physician follow-up

1.04

(0.85–1.28)

0.71

 Cardiologist follow-up

1.41

(1.14–1.75)

0.002

  1. Abbreviations: NYHA New York Heart Association, PCI percutaneous coronary intervention, CABG coronary-aorto bypass grafting